Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands

Clinical and Vaccine Immunology

Volumn 18, Issue 3, 2011, Pages 469-476

  Bodewes, R ^a   De Mutsert, G ^a   Van Der Klis, F R M ^b   Ventresca, M ^c   Wilks, S ^c   Smith, D J ^c   Koopmans, M ^a,b   Fouchier, R A M ^a   Osterhaus, A D M E ^a,d   Rimmelzwaan, G F ^a,d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d Viroclinics Biosciences BV   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MATERNAL ANTIBODY; VIRUS ANTIBODY; VIRUS ANTIGEN;

AGE; ANTIBODY DETECTION; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ARTICLE; BLOOD SAMPLING; CHILD; CHILD CARE; CONTROLLED STUDY; HEMAGGLUTINATION INHIBITION TEST; HIGH RISK POPULATION; HUMAN; INFANT; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; NETHERLANDS; PANDEMIC INFLUENZA; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; SCHOOL CHILD; SEASONAL INFLUENZA; SEASONAL VARIATION; SERODIAGNOSIS; SEROPREVALENCE; VIRUS ISOLATION; VIRUS STRAIN;

ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA, HUMAN; NETHERLANDS; SEROEPIDEMIOLOGIC STUDIES;

EID: 79952542635     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00396-10     Document Type: Article

References (43)

1. Bodewes, R., J. H. Kreijtz, and G. F. Rimmelzwaan. 2009. Yearly influenza vaccinations: a double-edged sword? Lancet Infect. Dis. 9:784-788.
2. Dawood, F. S., et al. 2009. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N. Engl. J. Med. 360:2605-2615.
3. De Jong, J. C., et al. 2003. Haemagglutination-inhibiting antibody to influenza virus. Dev. Biol. (Basel) 115:63-73.
4. de Jong, J. C., et al. 2005. The influenza season 2004/'05 in the Netherlands with the largest epidemic of the last 5 years caused by the virus variant A/California and the composition of the vaccine for the season 2005/'06. Ned. Tijdschr. Geneeskd. 149:2355-2361.
5. de Jong, J. C., et al. 2001. 2000/01 influenza season and the vaccine composition for the season 2001/'02. Ned. Tijdschr. Geneeskd. 145:1945-1950.
6. de Jong, J. C., et al. 2003. The 2002/2003 influenza season in the Netherlands and the vaccine composition for the 2003/2004 season. Ned. Tijdschr. Geneeskd. 147:1971-1975.
7. de Jong, J. C., et al. 2007. The 2006/'07 influenza season in the Netherlands and the vaccine composition for the 2007/'08 season. Ned. Tijdschr. Geneeskd. 151:2158-2165.
8. Fiore, A. E., et al. 2008. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recommend. Rep. 57(RR-7):1-60.
9. Fox, J. P., C. E. Hall, M. K. Cooney, and H. M. Foy. 1982. Influenzavirus infections in Seattle families, 1975-1979. I. Study design, methods and the occurrence of infections by time and age. Am. J. Epidemiol. 116:212-227.
10. Frank, A. L., et al. 1981. Patterns of shedding of myxoviruses and paramyxoviruses in children. J. Infect. Dis. 144:433-441.
11. Glezen, W. P., and R. B. Couch. 1978. Interpandemic influenza in the Houston area, 1974-76. N. Engl. J. Med. 298:587-592.
12. Gordon, A., et al. 2010. Clinical attack rate and presentation of pandemic H1N1 influenza versus seasonal influenza A and B in a pediatric cohort in Nicaragua. Clin. Infect. Dis. 50:1462-1467.
13. Griffiths, P. D., S. I. Berney, S. Argent, and R. B. Heath. 1982. Antibody against viruses in maternal and cord sera: specific antibody is concentrated on the fetal side of the circulation. J. Hyg. (Lond.) 89:303-310.
14. Hall, C. B., R. G. Douglas, Jr., J. M. Geiman, and M. P. Meagher. 1979. Viral shedding patterns of children with influenza B infection. J. Infect. Dis. 140:610-613.
15. Heikkinen, T., et al. 2006. Should healthy children be vaccinated against influenza? A consensus report of the Summits of Independent European Vaccination Experts. Eur. J. Pediatr. 165:223-228.
16. Heikkinen, T., and V. Peltola. 2009. Influenza vaccination of children. Lancet Infect. Dis. 9:720-721.
17. Irving, W. L., et al. 2000. Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study. BJOG 107:1282-1289.
18. Izurieta, H. S., et al. 2000. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N. Engl. J. Med. 342:232-239.
19. Johnson, B. F., et al. 2009. Fatal cases of influenza A in childhood. PLoS One 4:e7671.
20. Kanegae, Y., et al. 1990. Evolutionary pattern of the hemagglutinin gene of influenza B viruses isolated in Japan: cocirculating lineages in the same epidemic season. J. Virol. 64:2860-2865. (Pubitemid 20171276)
21. Luce, B. R., et al. 2008. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States. Vaccine 26:2841-2848.
22. Mossong, J., et al. 2008. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med. 5:e74.
23. Neuzil, K. M., B. G. Mellen, P. F. Wright, E. F. Mitchel, Jr., and M. R. Griffin. 2000. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N. Engl. J. Med. 342:225-231.
24. Paget, W. J., et al. 2010. Assessing the burden of paediatric influenza in Europe: the European Paediatric Influenza Analysis (EPIA) project. Eur. J. Pediatr. 169:997-1008.
25. Palmer, D., W. Dowle, M. Coleman, and G. Schild. 1975. Haemagglutination inhibition test, p. 25-62. In Advanced laboratory techniques for influenza diagnosis: procedural guide. U.S. Department of Health, Education, and Welfare, Atlanta, GA.
26. Puck, J. M., W. P. Glezen, A. L. Frank, and H. R. Six. 1980. Protection of infants from infection with influenza A virus by transplacentally acquired antibody. J. Infect. Dis. 142:844-849.
27. Reichert, T. A., et al. 2001. The Japanese experience with vaccinating school-children against influenza. N. Engl. J. Med. 344:889-896.
28. Reuman, P. D., E. M. Ayoub, and P. A. Small. 1987. Effect of passive maternal antibody on influenza illness in children: a prospective study of influenza A in mother-infant pairs. Pediatr. Infect. Dis. J. 6:398-403.
29. Rimmelzwaan, G. F., et al. 1999. Influenza season 1998/99; composition of vaccine for 1999/2000. Ned. Tijdschr. Geneeskd. 143:2015-2018.
30. Rimmelzwaan, G. F., et al. 2000. Influenza season 1999/2000 and vaccine composition for the season 2000/01. Ned. Tijdschr. Geneeskd. 144:1968-1971.
31. Rimmelzwaan, G. F., et al. 2006. The 2005-2006 influenza season in the Netherlands and the vaccine composition for the 2006-2007 season. Ned. Tijdschr. Geneeskd. 150:2209-2214.
32. Rimmelzwaan, G. F., et al. 2008. Influenza season 2007/'08 in the Netherlands: antigenic variation, oseltamivir resistance and vaccine composition for the 2008/'09 season. Ned. Tijdschr. Geneeskd. 152:2138-2144.
33. Ritzwoller, D. P., et al. 2005. Effectiveness of the 2003-2004 influenza vaccine among children 6 months to 8 years of age, with 1 vs 2 doses. Pediatrics 116:153-159.
34. Rota, P. A., et al. 1990. Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. Virology 175:59-68.
35. Salo, H., et al. 2006. Cost-effectiveness of influenza vaccination of healthy children. Vaccine 24:4934-4941. (Pubitemid 43782683)
36. Sauerbrei, A., R. Schmidt-Ott, H. Hoyer, and P. Wutzler. 2009. Seroprevalence of influenza A and B in German infants and adolescents. Med. Microbiol. Immunol. 198:93-101.
37. Shuler, C. M., et al. 2007. Vaccine effectiveness against medically attended, laboratory-confirmed influenza among children aged 6 to 59 months, 2003-2004. Pediatrics 119:e587-e595.
38. Steinhoff, M. C., et al. 2010. Influenza immunization in pregnancy - antibody responses in mothers and infants. N. Engl. J. Med. 362:1644-1646.
39. Tamma, P. D., M. C. Steinhoff, and S. B. Omer. 2010. Influenza infection and vaccination in pregnant women. Expert Rev. Respir. Med. 4:321-328.
40. van der Klis, F. R., L. Mollema, G. A. Berbers, H. E. de Melker, and R. A. Coutinho. 2009. Second national serum bank for population-based seroprevalence studies in the Netherlands. Neth. J. Med. 67:301-308.
41. Wutzler, P., R. Schmidt-Ott, H. Hoyer, and A. Sauerbrei. 2009. Prevalence of influenza A and B antibodies in pregnant women and their offspring. J. Clin. Virol. 46:161-164.
42. Yeolekar, L. R., P. B. Kulkarni, M. S. Chadha, and B. L. Rao. 2001. Seroepidemiology of influenza in Pune, India. Indian J. Med. Res. 114:121-126.
43. Zangwill, K. M., and R. B. Belshe. 2004. Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination. Pediatr. Infect. Dis. J. 23:189-197.